文献速递糖尿病

2型糖尿病成人心血管疾病与预期寿命:韩国全国样本队列研究

Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

基于韩国全国健康保险服务-全国样本队列中569,831名30岁以上参与者,2002至2006年入组、中位随访12.0年,按基线分为无糖尿病、仅糖尿病、糖尿病合并卒中、糖尿病合并心肌梗死、糖尿病合并卒中与心肌梗死五组。与参照组相比,各组合并心血管疾病后全因死亡风险与预期寿命损失随心血管共病增多而升高,且年轻人群的预期寿命损失更大。

要点

  • 糖尿病合并心血管共病越多,全因死亡风险越高,预期寿命损失越大
  • 仅糖尿病组全因死亡HR为1.70(95%CI 1.66至1.75)
  • 年轻亚洲2型糖尿病合并心血管共病者预期寿命损失更明显

核心结论

  • 年轻亚洲2型糖尿病合并心血管共病者的预期寿命短于无糖尿病人群,需特别关注以预防预期寿命进一步缩短。

研究设计与样本

  • 韩国全国健康保险服务-全国样本队列研究,纳入2002至2006年569,831名30岁以上参与者,中位随访12.0年。
  • 按基线疾病状态分为五组:无(参照组)、仅糖尿病、糖尿病合并卒中、糖尿病合并心肌梗死、糖尿病合并卒中与心肌梗死。

主要发现

  • 每1000人年死亡率:参照组6.85、仅糖尿病组19.86、糖尿病合并卒中组67.17、糖尿病合并心肌梗死组66.34、糖尿病合并卒中与心肌梗死组115.52。
  • 与参照组相比,全因死亡HR:仅糖尿病组1.70(95%CI 1.66至1.75)、糖尿病合并卒中组3.66(95%CI 3.32至4.03)、糖尿病合并心肌梗死组3.56(95%CI 3.06至4.14)、糖尿病合并卒中与心肌梗死组4.79(95%CI 3.05至7.50)。
  • 预期寿命损失在较年轻年龄更大,并随心血管代谢共病增多明显增加。

临床怎么用

  • 作者认为,年轻亚洲2型糖尿病合并心血管共病者需特别关注,以预防预期寿命进一步缩短。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although type 2 diabetes is a strong risk factor for cardiovascular disease and mortality, information on its association with mortality and life expectancy according to cardiovascular comorbidities is limited, especially in Asia. Thus, this study assessed mortality and reductions in life expectancy associated with cardiometabolic multimorbidity. DESIGN AND METHODS: A total of 569,831 participants older than 30 years from Korean National Health Insurance Service-National Sample Cohort were enrolled between 2002 and 2006 and followed for a median of 12.0 years. They were categorized into five mutually exclusive groups according to baseline disease status, as follows: none (reference group); diabetes only; diabetes and stroke; diabetes and myocardial infarction (MI); and diabetes, stroke, and MI. Mortality rates and hazard ratios (HRs), reductions of life expectancy, and age-specific contributions to life expectancy were calculated by constructing life tables. RESULTS: The mortality rates per 1000 person-years were 6.85, 19.86, 67.17, 66.34, and 115.52 in the reference, diabetes only; diabetes and stroke; diabetes and MI; and diabetes, stroke, and MI groups, respectively. The corresponding HRs for all-cause mortality were 1.70 [95% confidence interval (CI), 1.66 to 1.75], 3.66 (95% CI, 3.32 to 4.03), 3.56 (95% CI, 3.06 to 4.14), and 4.79 (95% CI, 3.05 to 7.50) compared with the reference group. The estimated reductions in life expectancy were greater at younger ages and markedly increased with more cardiometabolic comorbidities. CONCLUSION: Young Asians with type 2 diabetes, especially those with cardiovascular comorbidity, did not live as long than their nondiabetic equivalents. Thus, these individuals require special attention to prevent further reductions in life expectancy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kang YM, Cho YK, Lee SE, et al. Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study. J Clin Endocrinol Metab. 2017. PMID: 28911137. doi:10.1210/jc.2017-00643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。